The First Affiliated Hospital,College Of Medicine,Zhejiang University

Hangzhou 310003

2 studies enrolling now · 5 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute, Metastatic Breast Cancer, Multiple Myeloma, Newly Diagnosed Acute Myeloid Leukemia (AML), Small Cell Lung Cancer, Untreated AML, Waldenstrom Macroglobulinemia

Studies at this site

• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia — Completed
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed